Vicarious Surgical (RBOT) Revenue & Revenue Breakdown
Vicarious Surgical Revenue Highlights
Vicarious Surgical Revenue by Period
Vicarious Surgical Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | - |
Vicarious Surgical generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Vicarious Surgical Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $3.45M | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | - |
Vicarious Surgical generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Vicarious Surgical Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CNMD | CONMED | $1.24B | $332.10M |
| BVS | Bioventus | $512.35M | $151.22M |
| NVRO | Nevro | $425.17M | $101.90M |
| FNA | Paragon 28 | $216.39M | $61.02M |
| CTKB | Cytek Biosciences | $193.01M | $46.62M |
| KIDS | OrthoPediatrics | $148.73M | $52.80M |
| SIBN | SI-BONE | $138.89M | $39.97M |
| RXST | RxSight | $89.08M | $45.52M |
| SGHT | Sight Sciences | $81.06M | $21.37M |
| LUNG | Pulmonx | $68.67M | $20.78M |
| NPCE | NeuroPace | $65.42M | $18.12M |
| MXCT | MaxCyte | $41.29M | $11.34M |
| CVRX | CVRx | $39.30M | $11.81M |
| PROF | Profound Medical | $7.33M | $1.90M |
| OFIX | Orthofix Medical | $100.00K | $198.62M |
| RBOT | Vicarious Surgical | - | - |
RBOT Revenue FAQ
What is Vicarious Surgical’s yearly revenue?
Vicarious Surgical's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. RBOT's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Vicarious Surgical’s quarterly revenue?
Vicarious Surgical's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). RBOT's quarterly revenue for Q4 2023 was $3.45M, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is Vicarious Surgical’s revenue growth rate?
Vicarious Surgical's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.